Fortress Biotech Stock Annual Yield
| FBIO Stock | USD 1.94 0.05 2.51% |
Fortress Biotech fundamentals help investors to digest information that contributes to Fortress Biotech's financial success or failures. It also enables traders to predict the movement of Fortress Stock. The fundamental analysis module provides a way to measure Fortress Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Fortress Biotech stock.
Fortress | Annual Yield |
Fortress Biotech Company Annual Yield Analysis
Fortress Biotech's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Fortress Annual Yield Driver Correlations
Understanding the fundamental principles of building solid financial models for Fortress Biotech is extremely important. It helps to project a fair market value of Fortress Stock properly, considering its historical fundamentals such as Annual Yield. Since Fortress Biotech's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Fortress Biotech's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Fortress Biotech's interrelated accounts and indicators.
Click cells to compare fundamentals
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
Fortress Dividend Yield
Dividend Yield |
|
In accordance with the recently published financial statements, Fortress Biotech has an Annual Yield of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Fortress Annual Yield Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fortress Biotech's direct or indirect competition against its Annual Yield to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Fortress Biotech could also be used in its relative valuation, which is a method of valuing Fortress Biotech by comparing valuation metrics of similar companies.Fortress Biotech is currently under evaluation in annual yield category among its peers.
Fortress Biotech Current Valuation Drivers
We derive many important indicators used in calculating different scores of Fortress Biotech from analyzing Fortress Biotech's financial statements. These drivers represent accounts that assess Fortress Biotech's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Fortress Biotech's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 140.6M | 228.3M | 204.3M | 58.7M | 24.4M | 23.2M | |
| Enterprise Value | 118.9M | 84.0M | (26.5M) | 7.7M | 32.1M | 53.6M |
Fortress Fundamentals
| Return On Equity | -17.4 | ||||
| Return On Asset | -0.36 | ||||
| Profit Margin | (0.49) % | ||||
| Operating Margin | (1.69) % | ||||
| Current Valuation | 69.55 M | ||||
| Shares Outstanding | 27.56 M | ||||
| Shares Owned By Insiders | 21.20 % | ||||
| Shares Owned By Institutions | 14.46 % | ||||
| Number Of Shares Shorted | 2.82 M | ||||
| Price To Earning | (2.92) X | ||||
| Price To Book | 2.60 X | ||||
| Price To Sales | 0.69 X | ||||
| Revenue | 84.51 M | ||||
| Gross Profit | (85.66 M) | ||||
| EBITDA | (133.64 M) | ||||
| Net Income | (60.64 M) | ||||
| Cash And Equivalents | 208.35 M | ||||
| Cash Per Share | 1.92 X | ||||
| Total Debt | 88.59 M | ||||
| Debt To Equity | 1.24 % | ||||
| Current Ratio | 2.43 X | ||||
| Book Value Per Share | 0.79 X | ||||
| Cash Flow From Operations | (128.22 M) | ||||
| Short Ratio | 4.57 X | ||||
| Earnings Per Share | (27.73) X | ||||
| Price To Earnings To Growth | (0.10) X | ||||
| Target Price | 14.0 | ||||
| Number Of Employees | 186 | ||||
| Beta | 1.75 | ||||
| Market Capitalization | 46.86 M | ||||
| Total Asset | 167.53 M | ||||
| Retained Earnings | (694.87 M) | ||||
| Working Capital | 32.11 M | ||||
| Current Asset | 99.94 M | ||||
| Current Liabilities | 10.58 M | ||||
| Net Asset | 167.53 M |
About Fortress Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fortress Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fortress Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fortress Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Fortress Biotech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Fortress Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fortress Biotech will appreciate offsetting losses from the drop in the long position's value.Moving together with Fortress Stock
Moving against Fortress Stock
| 0.43 | SLS | Sellas Life Sciences | PairCorr |
| 0.42 | ERNA | Eterna Therapeutics | PairCorr |
| 0.4 | VALN | Valneva SE ADR | PairCorr |
| 0.4 | GNFT | Genfit | PairCorr |
The ability to find closely correlated positions to Fortress Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Fortress Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Fortress Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Fortress Biotech to buy it.
The correlation of Fortress Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Fortress Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Fortress Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Fortress Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Fortress Biotech Piotroski F Score and Fortress Biotech Altman Z Score analysis. To learn how to invest in Fortress Stock, please use our How to Invest in Fortress Biotech guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fortress Biotech. If investors know Fortress will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fortress Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (27.73) | Revenue Per Share 6.15 | Quarterly Revenue Growth (0.14) | Return On Assets (0.36) | Return On Equity (17.40) |
The market value of Fortress Biotech is measured differently than its book value, which is the value of Fortress that is recorded on the company's balance sheet. Investors also form their own opinion of Fortress Biotech's value that differs from its market value or its book value, called intrinsic value, which is Fortress Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fortress Biotech's market value can be influenced by many factors that don't directly affect Fortress Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fortress Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fortress Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fortress Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.